Commonwealth Fund

Affordable, quality health care. For everyone.

The rebound in visits is occurring across the U.S. The initial decrease in visits was most evident in the New England, Mid-Atlantic, and Pacific regions.

Ateev Mehrotra,
Michael Chernew,
David Linetsky,
Hilary Hatch,
and David Cutler
Add to ChartCart
Source:
The Impact of the COVID-19 Pandemic on Outpatient Visits: Practices Are Adapting to the New Normal

ChartCart

View

Add items to your ChartCart.

0 items are currently in your ChartCart

Related Charts

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

| Chart

Related Charts

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

| Chart
Since the nadir of visits in late March, there has been a substantial rebound in visits among people covered by Medicare. The rebound among people covered by Medicaid has lagged.

Since the nadir of visits in late March, there has been a substantial rebound in visits among people covered by Medicare. The rebound among people covered by Medicaid has lagged.

| Chart

Related Charts

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

The number of visits to ambulatory practices had declined nearly 60 percent by early April. Since that time, the numbers have rebounded substantially, though the rebound may be beginning to plateau.

| Chart
Since the nadir of visits in late March, there has been a substantial rebound in visits among people covered by Medicare. The rebound among people covered by Medicaid has lagged.

Since the nadir of visits in late March, there has been a substantial rebound in visits among people covered by Medicare. The rebound among people covered by Medicaid has lagged.

| Chart
In the past week, visits to some clinical specialties, such as dermatology and rheumatology, have returned to their baseline rates.

In the past week, visits to some clinical specialties, such as dermatology and rheumatology, have returned to their baseline rates.

| Chart
The decline in visits was greatest in those states that had an early surge in COVID-19 cases. Visits remain more depressed in these states.

The decline in visits was greatest in those states that had an early surge in COVID-19 cases. Visits remain more depressed in these states.

| Chart

Chart Details

Publication Date: June 25, 2020